NCT07101809 Trial of Ureteroscopy vs Steerable Continuous Flow Aspiration Technology
| NCT ID | NCT07101809 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Calyxo, Inc. |
| Condition | Urolithiasis |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2026-05-21 |
| Primary Completion | 2027-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2026-05-21 with a primary completion date of 2027-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to compare Steerable Ureteroscopic Renal Evacuation (SURE) using the CVAC System and standard ureteroscopy (URS) with laser lithotripsy for the treatment of urolithiasis. This is a prospective, randomized (1:1), multi-center study.
Eligibility Criteria
Inclusion Criteria: * Candidate for ureteroscopy with laser lithotripsy * Be willing and able to return for and respond to all study-related follow up procedures * Have been informed of the nature of the study and has provided informed consent using the IRB approved informed consent (ICF) Exclusion Criteria: * Untreated urinary tract infection at the time of the index procedure * Significant comorbidities * Bladder, ureteral or kidney abnormalities * Pregnant individuals * Unable to meet the treatment and follow up protocol requirements
Frequently Asked Questions
Who can join the NCT07101809 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Urolithiasis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07101809 currently recruiting?
Yes, NCT07101809 is actively recruiting participants. Visit ClinicalTrials.gov or contact Calyxo, Inc. to inquire about joining.
Where is the NCT07101809 trial being conducted?
This trial is being conducted at Birmingham, United States, Gainesville, United States, New York, United States, Bala-Cynwyd, United States and 1 additional location.
Who is sponsoring the NCT07101809 clinical trial?
NCT07101809 is sponsored by Calyxo, Inc.. The trial plans to enroll 150 participants.